Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges

Emerging Treatments for Esophageal Cancer: First-Line Metastatic Disease and Earlier Stages

Date

09 Sep 2022

Session

Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges

Topics

Tumour Site

Gastric Cancer;  Colon and Rectal Cancer;  Gastro-Oesophageal Junction Cancer

Presenters

Emmanuelle Samalin-Scalzi

Authors

E. Samalin-Scalzi

Author affiliations

  • Medical Oncology, ICM - Institut du Cancer de Montpellier, 34298 - Montpellier, Cedex 5/FR
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.